PTEN-deficient/GSI-resistant T-ALL cells move from NOTCH1 to Akt as their oncogene of choice and are extremely susceptible to Akt pathway inhibitors [75]. This evidence concerns the gene AKT1 and acute lymphoblastic leukemia.